Why the study?
There are concerns regarding the safe intraoperative and postoperative conduct of open-heart surgery in patients with hematological malignancy, and literature regarding this problem is limited.
Describes the clinical experience of performing open-heart surgery for mitral valve replacement in a patient with concurrent rheumatic heart disease and non-Hodgkin's lymphoma.
Answers are grounded in this paper and cite their sources.
Adds limited case data on open-heart surgery in hematological malignancy; hypothesis-generating and requires prospective confirmation before practice implications.
There are concerns regarding safe conduct of open-heart surgery in a patient with hematological malignancy, both in intraoperative and postoperative management of the patient. There is a paucity of literature regarding this problem and limited data have been published regarding the conduct of coronary artery bypass surgery on pump in a patient with hematological malignancies. We describe our experience in a patient with rheumatic heart disease with non-Hodgkin's lymphoma requiring mitral valve replacement.
No takes yet. Share an insight, caveat, or question.
Gupta et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: